Company
Singletto
Enabling antimicrobial performance in materials.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Customers
- research, manufacturing, and distribution partners
Claim, correct or request removal
Record updated 28 September 2026
About
Oxafence is Singletto’s materials-applied technology platform, with performance demonstrated in regulated applications and designed for integration into existing products.
Funding snapshot
- Total raised
- $11MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $100K2026-03-02
Funding rounds
- Round, 2026
- $100K2026-03-02, SEC form D sold, 1 investor
- Round, 2025
- $10.5M2025-04-15, SEC form D sold, 80 investors
- Round, 2024
- $65K2024-01-17, SEC form D sold, 1 investor
- Round, 2023
- $200K2023-05-05, SEC form D sold, 2 investors
- Round, 2021
- $50K2021-08-06, SEC form D sold, 1 investor
- Round, 2020
- $75K2020-09-22, SEC form D sold, 3 investors
Products
- Other
- Oxafence Active Protection
Loading relationship preview